Federal prosecutors are investigating Boston Children’s Hospital and others for allegedly misdiagnosing minors to obtain insurance coverage for puberty blockers not approved for gender dysphoria. DOJ filings cite a sharp rise in “precocious puberty” diagnoses among children over age 10—well beyond medical norms. Hospitals reportedly gained millions in reimbursements for gender treatments, sparking legal battles and federal scrutiny over possible fraudulent billing practices.
Federal probe uncovers potential fraud in child gender treatments at major hospitals
